This program is intended for the IBD care team including gastroenterologists, advanced practice providers that specialize in gastroenterology, internal medicine and family medicine physicians and advanced practice providers, nurses and other HCPs involved in the care of patients living with IBD.
The goal of this multicomponent, multiformat curriculum is to improve the knowledge and competence of community HCPs who care for patients living with ulcerative colitis and Crohn’s disease.
Upon completion of this activity, participants should be able to:
Apply recommended strategies for collaborative care and holistic patient care methodologies for IBD
All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Bruce E. Sands, MD, MS: consultant/advisor/speaker: AbbVie, Amgen, Arena Pharmaceuticals, AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Celltrion, Fresenius Kabi, Genentech, GlaxoSmithKline, Janssen, Lilly, Merck, Pfizer, Sun Pharma, Takeda, Teva.
Abigail Meyers, PA-C: has no relevant financial relationships to disclose.
The planners and content peer reviewers from Partners for Advancing Clinical Education, the American Gastroenterological Associate, Practicing Clinicians Exchange, and Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Kimberly Kearns, MS, APN-BC as noted below:
Kimberly Kearns, MS, APN-BC: consultant/advisor/speaker: Lilly, Janssen, Salix
The program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Joint Accreditation Statement
In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing Continuing Education
ANCC Credit Designation
Nursing contact hours: 0.25, which includes 0.25 hours of pharmacology credit
Nurse Course Advisor: Kimberly Kearns, MS, APN-BC, Duly Health and Care, Hoffman Estates, Illinois
Physician Assistant/Physician Associate Continuing Medical Education
AAPA Credit Designation
Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award 0.25 AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until January 19, 2024. PAs should only claim credit commensurate with the extent of their participation.
PA Course Advisor: Abigail Meyers, PA-C, Mayo Clinic, Rochester, Minnesota
Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 25, 2023, through January 24, 2024:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.